ALNYAlnylam Pharmaceuticals

Median target
$388.5
calls from the last 12 months
Implied return
+58.2%
median target vs. price
Coverage
27 analysts · 32 calls
updated in the last 12 months
Consensus
21/6/0+21 net
Buy / Hold / Sell

Which analysts are behind ALNY's consensus?

See every current rating, price target and the analysts' track records for Alnylam Pharmaceuticals — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 27 analysts with calls on ALNY updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ALNY elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-02-19ExecutiveTrump, Donald JPresidentTransactionALNYLAM PHARMACEUTICALS INC$1,001 - $15,000
2026-01-23ExecutiveTrump, Donald JPresidentTransactionALNYLAM PHARMACEUTICALS INC
2025-12-16ExecutiveTrump, Donald JPresidentSaleALNYLAM PHARMACEUTICALS INC$1,001 - $15,000
2025-12-11ExecutiveTrump, Donald JPresidentSaleAlnylam Pharmaceuticals, Inc.$15,001 - $50,000
2025-09-16ExecutiveTrump, Donald JPresidentPurchaseALNYLAM PHARMACEUTICALS INC$1,001 - $15,000
2025-08-27ExecutiveTrump, Donald JPresidentPurchaseAlnylam Pharmaceuticals, Inc.$15,001 - $500,008
2025-08-15ExecutiveTrump, Donald JPresidentPurchaseALNYLAM PHARMACEUTICALS INC$1,001 - $15,000
2025-07-15ExecutiveTrump, Donald JPresidentPurchaseALNYLAM PHARMACEUTICALS INC$1,001 - $15,000
2025-06-13ExecutiveTrump, Donald JPresidentPurchaseALNYLAM PHARMACEUTICALS INC$1,001 - $15,000
2025-05-23ExecutiveTrump, Donald JPresidentPurchaseAlnylam Pharmaceuticals, Inc.$1,001 - $150,005

More: congressional trades on ALNY · insider activity · executive branch · trending